SYNTHESIS AND PHARMACOLOGY OF THE NEW ANTIMICROBIAL DRUG AIP-10
Keywords:
амиды, adamantanecarbonyl chloride, thiomorpholine, antimicrobial activity, fungicidal activityAbstract
In present research, amide adamantanecarboxylic acid was synthesized according to the Schotten-Bauman by the method acylation of thiomorpholine with adamantanecarbonyl chloride, in order to obtain a pharmacologically acceptable form, the drug AIP-10 was synthesized in combination with β-cyclodextrin, which showed antimicrobial and fungicidal activity in the practice of in vitro. The reaction was carried out in absolute benzene with cooling and the ratio amine: acylating agent = 2: 1. The composition and structure of the synthesized compounds were confirmed by elemental analysis and IR, NMR spectroscopy, individuality - by thin-layer chromategraphy.
References
[1] Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000–2016. Geneva: World Health Organization, 2018. [Jelektronnyj resurs]. – Rezhim dostupa: https://www.who.int/ru/news-room/fact-sheets/detail/the-top-10-causes-of-death
[2] Tacconelli E., Carrara E., Savoldi A., Harbard S., Mendelson M. et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis // Lancet Infect. Dis. 2018. Vol. 18, No 3. P. 318-327.
[3] Asher M. New drugs cost US $ 2,6 billion to develop // Nature reviews drug discovery. 2014. P. 877.
[4] Cars O., Hedin A., Heddini A. The global need for effective antibiotics – moving towards concerted action // Drug resistance updates. 2011. Vol. 14, No 2. P. 68-69.
[5] Sharland M., Pulcini C., Harbarth S., Zeng M., Gandra S., Mathur S., Magrini N. Classifying antibiotics in the WHO Essential Medicines List for optimal use-be AWaRe // Lancet Infect. Dis. 2018. Vol. 18, No 1. P. 18-20.
[6] Galewicz-Walesa K., Pachuta-Stec A. The synthesis and properties of N-substituted amides of 1-(5-methylthio-1, 2, 4-triazol-3-yl) - cyclohexane-2-carboxylic acid// Medical Academy in Lublin. 2003. Vol. 9. P. 118-125.
[7] Kushwaha N., Saini R.K., Kushwaha S.K.S. Synthesis of some amide derivatives and their biological activity // International Journal of ChemTech Research. 2011. Vol. 3. P. 203-209.
[8] Firdaus, Husain D., Naid T., Soekamto N., Sumarna S., Islam M.F. Synthesis of piperidine and morpholine amides of ferrulic acid and their bioactivity against P-388 Leukemia cells // International Journal of ChemTech Research. 2017. Vol. 10. P. 27-33.
[9] Ahmetova G.S., Ospanova S.I., Sultanova D.A., Ju V.K., Sadyrbaeva F.M., Praliev K.D. Sintez novyh amidov ciklopropankarbonovoj kisloty // Izvestija nauchno-tehnicheskogo obshhestva «KAHAK». 2016. No 4(55). P. 24-30.
[10] Moiseev I.K., Kon'kov S.A., Ovchinnikov K.A. i dr. Sintez i protivovirusnaja aktivnost' novyh proizvodnyh adamantanovogo rjada // Himiko-farmacevticheskij zhurnal. 2011. Vol. 45, No 10. P. 9-13.
[11] Shibnev V.A., Garaev T.M., Finogenova M.P. i dr. Nekotorye puti preodolenija rezistent-nosti virusov grippa A k preparatam adamantanovogo rjada // Himiko-farmacevticheskij zhurnal. 2012. Vol. 46, No 1. P. 3-7.
[12] Hassan G.S., El-Emam A.A., Gad L.M., Barghash E.A.M. Synthesis, antimicrobial and antiviral testing of some new 1-adamantyl analogues // Saudi Pharm. J. 2010. Vol. 18. P. 123-128.
[13] Hassan G.S., El-Emam A.A., Gad L.M., Barghash A.M. Synthesis, antimicrobial and antiviral testing of some new 1-adamantyl analogues // Saudi Pharm. J. 2010. Vol. 18. P. 123-128.
[14] Zhu X.-h., Sun J., Wang Sh., Bu W., Yao M.-n., Gao K., Song Y., Zhao J.-y., Lu Ch.-t., Zhang E.-h., Yang Zh.-f., Wen A.-d. Synthesis, crystal structure, superoxide scavenging activity, anticancer and docking studies of novel adamantyl nitroxide derivatives // J. of Molec. Struc. 2016. Vol. 1108. P. 611-617.
[15] O’Brien-Brown J., Jackson A., Reekie T.A., Barron M.L., Werry E.L., Schiavini P., McDonnell M., Munoz L., Wilkinson Sh., Noll B., Wang Sh., Kassiou M. Discovery and Pharma-cological Evaluation of a Novel Series of Adamantyl Cyanoguanidines as P2X7 Receptor Antagonists // Eur. J. Med. Chem. 2017. Vol. 21, No 130. P. 433-439.
[16] CLSI M100-S25. Performance Standards for Antimicrobial Susceptibility Testing // CLSI. 2015. Vol. 35, No 3. 236 p.
[17] CLSI M27-A2. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast // CLSI. 2002. Vol. 22, No 15. 51 p.
[18] Semina N.A. Metodicheskie ukazanija po opredeleniju chuvstvitel'nosti mikroorganizmov k antibakterial'nym preparatam / N.A. Semina, S.V. Sidorenko, S.P. Rezvan, S.A. Grudinina, L.S. Strachunskij, O.U. Stecjuk, R.S. Kozlov, M.V. Jejdel'shtej, E.A. Ved'mina, L.G. Stoljarova, I.V. Vlasovan, Z.S. Sereda / Federal'nyj centr gossanjepidnadzora Minzdrava Rossii. M., 2004. 53 p.